Host-diet-gut Microbiome Interactions Influence Human Energy Balance: a Randomized Clinical Trial
Overview
Authors
Affiliations
The gut microbiome is emerging as a key modulator of human energy balance. Prior studies in humans lacked the environmental and dietary controls and precision required to quantitatively evaluate the contributions of the gut microbiome. Using a Microbiome Enhancer Diet (MBD) designed to deliver more dietary substrates to the colon and therefore modulate the gut microbiome, we quantified microbial and host contributions to human energy balance in a controlled feeding study with a randomized crossover design in young, healthy, weight stable males and females (NCT02939703). In a metabolic ward where the environment was strictly controlled, we measured energy intake, energy expenditure, and energy output (fecal and urinary). The primary endpoint was the within-participant difference in host metabolizable energy between experimental conditions [Control, Western Diet (WD) vs. MBD]. The secondary endpoints were enteroendocrine hormones, hunger/satiety, and food intake. Here we show that, compared to the WD, the MBD leads to an additional 116 ± 56 kcals (P < 0.0001) lost in feces daily and thus, lower metabolizable energy for the host (89.5 ± 0.73%; range 84.2-96.1% on the MBD vs. 95.4 ± 0.21%; range 94.1-97.0% on the WD; P < 0.0001) without changes in energy expenditure, hunger/satiety or food intake (P > 0.05). Microbial 16S rRNA gene copy number (a surrogate of biomass) increases (P < 0.0001), beta-diversity changes (whole genome shotgun sequencing; P = 0.02), and fermentation products increase (P < 0.01) on an MBD as compared to a WD along with significant changes in the host enteroendocrine system (P < 0.0001). The substantial interindividual variability in metabolizable energy on the MBD is explained in part by fecal SCFAs and biomass. Our results reveal the complex host-diet-microbiome interplay that modulates energy balance.
Metagenomic estimation of dietary intake from human stool.
Diener C, Holscher H, Filek K, Corbin K, Moissl-Eichinger C, Gibbons S Nat Metab. 2025; .
PMID: 39966520 DOI: 10.1038/s42255-025-01220-1.
Rampanelli E, Romp N, Troise A, Ananthasabesan J, Wu H, Gul I Microbiome. 2025; 13(1):15.
PMID: 39833973 PMC: 11744835. DOI: 10.1186/s40168-024-02002-9.
Chandra A, Espiche C, Maliha M, Virani S, Blumenthal R, Rodriguez F Am J Prev Cardiol. 2025; 21:100919.
PMID: 39802677 PMC: 11722599. DOI: 10.1016/j.ajpc.2024.100919.
A whole food, plant-based diet reduces amino acid levels in patients with metastatic breast cancer.
Scales T, Smith B, Blanchard L, Wixom N, Tuttle E, Altman B Cancer Metab. 2024; 12(1):38.
PMID: 39702320 PMC: 11657127. DOI: 10.1186/s40170-024-00368-w.
Unraveling the Gut Microbiota: Implications for Precision Nutrition and Personalized Medicine.
Abeltino A, Hatem D, Serantoni C, Riente A, Giulio M, De Spirito M Nutrients. 2024; 16(22).
PMID: 39599593 PMC: 11597134. DOI: 10.3390/nu16223806.